This is an Erasmus+ International Credit Mobility project of Leiden University’s Faculty of Medicine with Kilimanjaro Christian Medical Center in Tanzania.

Helping cancer patients with treatment choices.

Pancreatic ductal adenocarcinoma (PDAC) is the deadliest common cancer, with only 8% of patients surviving for five years. One reason for this poor outcome is that current chemotherapy treatments are highly toxic, often leaving patients too sick to receive treatment or forcing doctors to lower the dose…

Find out more about the impact of Brexit on research projects.

One Lecture about Immigrant Integration in the EU and its Member State at the Institute of European Studies at George Washington University, one class in a course on Immigration and Integration at Georgetown University, and a lot of judging in the international rounds of the Phillip C. Jessup International…

Eva Michaels & Monika Sus examines European Strategic Autonomy (ESA) as the EU’s response to the fragmentation of the Liberal International Order.

The Europaeum is a network of 17 leading European universities, whose aim is to bring together talented students and teachers and to promote a 'European feeling' through cooperation and academic mobility.

We study how communication can heal and harm when patients are confronted with an illness. Most of our studies focus on serious illnesses such as advanced cancer. Communication lies at the heart of medicine, yet we do not always know which specific communication helps patients. Moreover, many complaints…

PhD defence

PhD defence

PhD defence

To get a feeling of how we operate at LED3 when it comes to Early Drug Discovery, please browse through our case studies. When you select a case study you’ll find relevant contacts.

In this project, we aim to obtain a quantitative understanding of the role of the immune system in tumor regression, of the role of tumor cell heterogeneity in cancer growth and of tumor cell migration properties.

Our research in the area of safety sciences aims to increase the mechanistic understanding of cellular toxicity of drugs and, in a broader sense, chemicals.

Molecular Physiology is a research group at the Leiden Institute of Chemistry dedicated to the design, synthesis and application of chemical tools to study important biological and biomedical questions. The group is headed by Prof. Dr. Mario van der Stelt and includes the research lines of Assistant…

Promotores: B. van de Water; P. Hogendoorn; J. Bovée Co-Promotor: E.H.J. Danen

Animal Sciences’ contribution to the Bioactive Molecules research theme includes research on molecules from natural sources, such as plants, insects, and snake venom, with the aim to identify novel anti-cancer, anti-inflammatory, anti-microbial, and anti-diabetic agents.

Promotor: T. Schmidt, Co-Promotor: B.E. Snaar-Jagalska

Inactivating mutations in BRCA1 or BRCA2 genes predispose to several types of cancer.

Source: Nature Biotechnology, Volume 2014, Issue June (2014)

Glycosidases (GHs) are enzymes responsible for the degradation of carbohydrates and play many roles in human health and pathophysiology. Often, abnormal levels of glycosidase activity are markedly linked to human pathologies.

Animal Sciences’ contributions to the Development & Disease research theme include the mechanisms and evolution of embryonic development, the development of cognitive mechanisms, and animal models for understanding mechanisms of human disease.

Cell adhesion signaling

Overkleeft

These awards honour researchers who turn scientific insight into real-world impact. From master’s students to postdocs, they highlight exceptional work in life sciences, health sciences, biotech, or environmental health sciences with data science at the core. Meet the 2025 winners.

Lecture, Tuesday Talks: Science Insights

PhD defence

On 29 January 2019, CBC News, Canada’s largest news broadcaster, interviewed Dr. Joris Larik about the status of the Comprehensive Economic and Trade Agreement (CETA) between the EU and Canada.

Metal-containing molecules combine geometrical features and a reactivity that are inherently different from that of organic molecules. My research focuses on light-activatable metal-based anticancer drugs and metal-functionalized liposomes. Light is a very selective way to activate photosensitive drugs…

Last week, Dr. Joris Larik, Assistant Professor of Comparative, EU and International Law at Leiden University College and convener of the International Justice major, gave a presentation at the Second World Meeting of Societies for International Law at the Peace Palace in The Hague.

The majority (80%) of e-waste generated globally are recycled informally in developing countries.

Improving health, enhancing well-being and reducing health disparities across society.

Promotor: E. Bouwman, Co-promotor: S. Bonnet

Promotor: H.S. Overkleeft, J. Neefjes, Co-promotor: M. van der Stelt

New or improved treatments for chronic and acute illness.

Dr. Joris Larik, Assistant Professor of Comparative, EU and International Law at LUC The Hague, has co-authored a report entitled 'UN 2.0: Ten Innovations for Global Governance 75 Years beyond San Francisco'.

Under what circumstances do paramilitary groups limit their use of political violence? This article examines the use of political violence by the PIRA.

On 27 September 2017 a new book by Prof. Luuk van Middelaar appeared, entitled The new politics of Europe. The book is at the same time a front line account of Europe’s recent crisis years – from monetary turmoil to tensions around Ukraine, from refugee crisis to Brexit – and an analysis of the Union’s…

Valedictory lecture

PhD defence

PhD defence

PhD defence

A consortium of research groups, including that of LACDR professor Erik Danen, will use an NWO Perspective grant of nearly five million euros to build a universal standard for organ-on-chip models. They aim to stimulate the application of these chips in the biomedical and pharmaceutical industry. Danen…

By carrying out fundamental research and providing excellent education, universities become a breeding ground for innovation and entrepreneurship.

The Leiden University Medical Center (LUMC) is committed to improving healthcare and the health of individuals. The LUMC staff put this mission into practice on a daily basis with their leading research, cutting-edge teaching and optimal, innovative healthcare.

An overview of the research at the Biologics Formulation group

There are many complex links in the chain that provides patients with new drugs: from fundamental science, to clinical tests, to production. The entire chain can be found in Leiden. Leiden University, the Leiden University Medical Center (LUMC) and the businesses at the Leiden Bio Science Park (LBSP)…

The Novel chemical modalities research group is headed by Assistant Professor Sebastian Pomplun. Sebastian started at the division of Medicinal Chemistry within the LACDR in September 2021. His lab develops technologies for the discovery of novel chemical modalities that can address challenging drug…

Analysis of drug adversity